Approval Delays For Transcept's Insomnia Drug Come At A Price; Milestone Payments At Stake
This article was originally published in The Pink Sheet Daily
Executive Summary
Transcept expects Purdue to pay a significantly lower approval milestone payment for Intermezzo given regulatory delays.